Inference costs are pushing the largest AI companies toward their own silicon, while US and EU regulators move from principle to operational detail — and buyers are told to run AI spending as a portfolio.
It turns a vague budget question into answerable ones, giving finance and business owners a concrete frame for AI allocation decisions.
After OpenAI's Broadcom chip, major AI firms are accelerating vertical integration into semiconductors to contain inference cost.
A change to the EU regulatory timetable directly affects the priorities and preparation time of every company in scope.
Federal clarity on conflicting state requirements bears directly on the risk management of any company running AI products in the United States.
Against sharply rising inference costs, the major AI companies are accelerating the internalisation of their compute foundations, custom chip development included.
The US and Europe have both entered the phase of making AI regulation concrete — output accuracy, transparency duties, application dates — raising the practical compliance load.
On the buyer side, the argument is widening from raising AI budgets opportunistically to managing them as a portfolio with explicit criteria.
Whether the Samsung discussions turn into a confirmed agreement, and what the FTC files after its comment period closes on 31 July 2026.